PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33767939-3	2021	The aim of this study was to investigate the therapeutic effects of the combination of erythropoietin and methylprednisolone in the treatment of ischemia-reperfusion injury to the spinal cord and to analyze its effects on the levels of interleukin-1 beta (IL-1beta), interleukin-1 receptor antagonist (IL-1RA), and interleukin-8 (IL-8).	Methylprednisolone	106-124	interleukin 1 alpha	Homo sapiens	256-264	
33767939-3	2021	The aim of this study was to investigate the therapeutic effects of the combination of erythropoietin and methylprednisolone in the treatment of ischemia-reperfusion injury to the spinal cord and to analyze its effects on the levels of interleukin-1 beta (IL-1beta), interleukin-1 receptor antagonist (IL-1RA), and interleukin-8 (IL-8).	Methylprednisolone	106-124	interleukin 1 receptor antagonist	Homo sapiens	267-300	
33767939-3	2021	The aim of this study was to investigate the therapeutic effects of the combination of erythropoietin and methylprednisolone in the treatment of ischemia-reperfusion injury to the spinal cord and to analyze its effects on the levels of interleukin-1 beta (IL-1beta), interleukin-1 receptor antagonist (IL-1RA), and interleukin-8 (IL-8).	Methylprednisolone	106-124	interleukin 1 receptor antagonist	Homo sapiens	302-308	
33767939-3	2021	The aim of this study was to investigate the therapeutic effects of the combination of erythropoietin and methylprednisolone in the treatment of ischemia-reperfusion injury to the spinal cord and to analyze its effects on the levels of interleukin-1 beta (IL-1beta), interleukin-1 receptor antagonist (IL-1RA), and interleukin-8 (IL-8).	Methylprednisolone	106-124	C-X-C motif chemokine ligand 8	Homo sapiens	315-328	
33767939-3	2021	The aim of this study was to investigate the therapeutic effects of the combination of erythropoietin and methylprednisolone in the treatment of ischemia-reperfusion injury to the spinal cord and to analyze its effects on the levels of interleukin-1 beta (IL-1beta), interleukin-1 receptor antagonist (IL-1RA), and interleukin-8 (IL-8).	Methylprednisolone	106-124	C-X-C motif chemokine ligand 8	Homo sapiens	330-334